Breaking News, Financial News

Financial Report: Roche

Nutley closure impacts earnings

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Roche   1H Revenues: $25.5 billion (+4%) 1H Earnings: $4.6 billion (-14%) Comments: Pharmaceutical sales were $18.2 billion (+4%). Growth in the half was driven by cancer medicines, hepatitis drug Pegasys, rheumatoid arthritis treatment Actemra/RoActemra and the clinical lab business. Earnings decline was mainly due to costs related to closure of Nutley, NJ operations and productivity measures in Applied Science and Diabetes Care....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters